life-threatening Tagged Articles
Newborn’s long list of birth defects blamed on antidepressant Zoloft
Use of the antidepressant Zoloft during pregnancy is considered the primary cause of a long list of serious birth defects in a newborn. The case was reported last year to the Food and Drug Administration (FDA) Adverse Event Reporting Program,
FDA warns of low IQ in children born to women taking anti-seizure drug valproate
The Food and Drug Administration (FDA) is warning doctors not to prescribe the anti-seizure drug Valproate to pregnant women for the prevention of migraine headaches because there is evidence that the drug can cause decreased IQ scores in children whose
FDA approves new reversal agent for blood thinner warfarin
The Food and Drug Administration (FDA) has approved Kcentra (Prothrombin Complex Concentrate, Human) for patients who need an immediate reversal of the anti-clotting effects of the blood thinner warfarin. Until now, plasma was the only product approved in the United
Anti-seizure drugs tied to skin discoloration, eye abnormalities
The Food and Drug Administration (FDA) is warning the public that the anti-seizure medication Potiga (ezogabine) can cause blue skin discoloration and eye abnormalities characterized by pigment changes in the retina. The changes may not be reversible. As a result,
New study shows energy drinks can raise blood pressure, cause abnormal heart rhythm
A new study shows that energy drinks, such as Red Bull, Monster, and 5-Hour Energy, may increase blood pressure and cause erratic heartbeat.
School bans Axe body spray after student suffers life threatening allergic reaction
Officials at a Pennsylvania high school have banned Axe Body Spray from students during school hours after a teenage student suffered a life threatening allergic reaction.
FDA to review new type 2 diabetes treatment
The Food and Drug Administration (FDA) has started a review of Sanofi’s new once-daily type 2 diabetes drug lixisenatide. The drug was approved last month by European Union regulators, and will be marketed as Lyxumia. Sanofi has not yet selected
Bayer’s profits take a hit due to Yaz lawsuits
Lawsuits against the birth control pill Yaz took a huge bite out of Bayer’s fourth quarter profits. The company reported net profits of $490 million, a far cry from the $519 million it brought in last year.
Indiana Board of Pharmacy revokes license of pharmacy blamed for meningitis outbreak
The Indiana Board of Pharmacy has revoked the license of New England Compounding Center (NECC), the Massachusetts-based specialty pharmacy that produced and distributed nationwide contaminated steroid shots tied to a deadly fungal meningitis outbreak. NECC will not be allowed to
Did Takeda know cancer risk with diabetes drug Actos years before placing warning on label?
Takeda Pharmaceutical Co. executives were so concerned about the bladder cancer risks with the company’s type 2 diabetes drug Actos that they secretly polled doctors to see if they would prescribe a drug that had a cancer warning on its